EFFICACY OF TANAKAN IN THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC BRAIN ISCHEMIA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper discusses the clinical aspects of the impact of chronic brain ischemia on cerebral cortical structures to develop impairments in higher nervous activity and cognitive (gnostic) functions. It gives the results of using Tanakan® to treat cognitive impairments in patients with chronic brain ischemia.

Full Text

Restricted Access

About the authors

E. Solovyeva

N.I. Pirogov Russian National Research Medical University

Email: ellasolovieva@yandex.ru
Professor MD Moscow

A. Karneyev

N.I. Pirogov Russian National Research Medical University

Professor MD Moscow

References

  1. Верещагин Н.В., Пирадов М.А., Суслина З.А. Инсульт: принципы диагностики, лечения и профилактики / М.: Интермедика, 2002; 208 с.
  2. Гусев Е.И., Скворцова В.И. Ишемия головного мозга / М., 2001; с. 45-98.
  3. Дамулин И.В. Сосудистые когнитивные нарушения: клинические и терапевтические аспекты // РМЖ. - 2006; 14 (9): 658-64.
  4. Захаров В.В. Умеренные когнитивные расстройства. Диагностика и лечение // РМЖ. - 2006; 14, 9 (261): 685-8.
  5. Маньковский Б.Н., Слонимская В.М. Гипертонические энцефалопатии // Врачебное дело. - 1959; 7.
  6. Скворцова В.И. Нейропротективная стратегия ишемического инсульта // Врач. - 2004; 6: 26-32.
  7. Федин А.И., Румянцева С.А. Избранные вопросы базисной интенсивной терапии нарушений мозгового кровообращения / М.: Интермедика, 2002; 256 с.
  8. Andrieu S., Ousset P., Coley N. et al. GuidAge study GROUP // Curr. Alzheimer. Res. - 2008; 5 (4): 406-15.
  9. Bridi R., Crossetti F., Steffen V. et al. The antioxidant activity of standartized extract of Ginkgo biloba (EGb 761) in rats // Phytother. Res. - 2001; 15: 449-51.
  10. Chui et al. Clinical Criteria for the Diagnosis of Vascular Dementia: A Multicenter Study of Comparability and Interrater Reliability // Arch. Neurol. -2000; 57: 191-6.
  11. DeKosky S., Fitzpatrick A., Ives D. The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extracts in prevention of dementia // Contempor. Clin. Trials. - 2006; 27: 238-53.
  12. Gupta C. Phospholipids in disease. In: Phospholipids Handbook.G. Cevc, ed. Marcel Dekker. - 1993; p. 895-905.
  13. Huquet F., Drieu K., Piriou K. Decreased cerebral 5-HT 1a receptors during aging: reversal by Ginkgo biloba extract (EGb 761) // J. Pharm. Pharmacol. - 1994; 46: 316-8.
  14. Kristofikova Z., Benesova O., Tejkalova H. Changes of high-affinity choline uptake in the hippocampus of old rats after long-term administration of two nootropic drugs (Tacrine and Ginkgo biloba extract) // Dementia. - 1992; 3: 304-7.
  15. LeBars P., Katz M., Berman N. et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia // JAMA. - 1997; 278: 1327-32.
  16. Mairs I., Marocci L., Droy-Lefaix M. et al. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761 // Biochem. Pharmacol. - 1995; 49: 1649-55.
  17. Pardon M., Joubert C., Perz-Diaz F. et al. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761) // Mech. Ageing Dev. -2000; 113: 157-68.
  18. Roman G., Tatemichi T., Erkinjuntti T. et al. Vascular dementia-diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop // J. Neurol. - 1993; 43: 250-60.
  19. Stoll S., Scheuer K., Pohl O. et al. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse // Pharmacopsych. - 1996; 29: 144-9.
  20. Sun B., Hu Y., Yuan H. et al. Extract of Ginkgo biloba promotes the expression of VEGF followed subarachnoid hemorrhage in rats // Int. J. Neurosci. - 2009; 119: 995-1005.
  21. Tchantchou F., Xu Y., Wu Y. et al. EGb 761 enhances adult hippocampal neurogenesis and phosphorilation of CREB in transgenic mouse model of Alzheimer’s disease // FASEB J. - 2007; 21: 2400-8.
  22. Timiras P. Physiological Basis of Aging and Geriatrics. N.Y. CRC Press. -2003; 384 p.
  23. Vellas B., Andrieu S., Ousset P. Methodological issues. A 5-year doubleblind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint // Neurology. - 2006; 67 (9): 6-11.
  24. Williams B., Watanabe C., Schultz P. Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability // Neurobiol. Aging. - 2004; 25 (7):955-62.
  25. Yao Z., Han Z., Drieu K. et al. Ginkgo biloba extract (EGb 761) inhibits betaamyloid production by lowering free cholesterol levels // Nutr. Biochem. - 2004; 15 (12): 749-56.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Russkiy Vrach Publishing House